Endologix receives FDA approval for stent system
Medical device maker Endologix Inc. said Wednesday that the Food and Drug Administration has approved its AFXT Endovascular AAA System for treating abdominal aortic aneurysms.
The Irvine, Calif., company said it will introduce the product at the annual meeting of the Society for Vascular Surgery in Chicago later this week.
An abdominal aortic aneurysm is a weakening of the wall of the aorta, the largest artery in the body. This leads to a balloon-like enlargement that can rupture. Endologix's system delivers a stent that redirects blood flow away from the aneurysm and reduces pressure on it. The stent is inserted through an artery in the groin.
Stents are mesh-wire tubes used to stabilize arteries and hold them open.
Endologix said the AFXT Endovascular AAA System is its latest version of the product. It offers a mechanism that makes it easier for the surgeon to deploy the stent inside the artery.
Shares of Endologix climbed 21 cents, or 2.7 percent, to $7.83 in trading Wednesday.